{
  "articles": [
    {
      "path": "about.html",
      "title": "Brendan J. Kelly",
      "author": [],
      "contents": "\n\n          \n      \n      Brendan J. Kelly\n      \n      \n      About\n      Projects\n      Publications\n      \n      \n      Teaching\n       \n      ▾\n      \n      \n      Intro to Epidemiology\n      Microbiome Measures\n      \n      \n      News\n      \n      \n      \n      \n      \n      \n      \n      \n      \n      ☰\n      \n      \n      \n        \n          \n            \n              \n            \n              Brendan J. Kelly\n            \n            \n              \n                \n                    \n                      \n                        Twitter\n                      \n                    \n                  \n                                    \n                    \n                      \n                        GitHub\n                      \n                    \n                  \n                                    \n                    \n                      \n                        PubMed\n                      \n                    \n                  \n                                    \n                    \n                      \n                        CV\n                      \n                    \n                  \n                                  \n            \n          \n        \n        \n        \n          \n            Brendan J. Kelly, M.D., M.S., studies infectious diseases and epidemiology at the University of Pennsylvania. His research focuses on microbial ecosystems in humans at high risk for infection. Dr. Kelly seeks to understand properties of microbial ecosystems that protect against infection, how microbial ecosystems are altered by antibiotics, and how microbial ecosystems recover from infection and antibiotic treatment. He has performed large, clinical-translational studies to better understand pneumonia and intestinal infections that occur in the setting of critical illness. Dr. Kelly’s work has been supported by the National Institute of Allergy and Infectious Diseases (NIAID) and the Centers for Diseases Control and Prevention (CDC).\n            \n            Education\n            University of Pennsylvania | Philadelphia, PA\n            M.S. in Clinical Epidemiology | July 2011 - August 2013\n            Columbia University College of Physicians & Surgeons | New York, NY\n            M.D. | August 2002 - June 2007\n            Harvard University | Cambridge, MA\n            A.B. in History and Science | September 1998 - June 2002\n            \n            \n            Appointments\n            Assistant Professor of Medicine & Epidemiology | Perelman School of Medicine | University of Pennsylvania\n            Senior Scholar | Center for Clinical Epidemiology & Biostatistics | University of Pennsylvania\n            \n          \n        \n      \n    \n\n    \n      \n        \n          \n            \n              \n            \n              Brendan J. Kelly\n            \n            \n              \n                \n                                    \n                    \n                      Twitter\n                    \n                  \n                                    \n                    \n                      GitHub\n                    \n                  \n                                    \n                    \n                      PubMed\n                    \n                  \n                                    \n                    \n                      CV\n                    \n                  \n                                  \n              \n            \n            \n              Brendan J. Kelly, M.D., M.S., studies infectious diseases and epidemiology at the University of Pennsylvania. His research focuses on microbial ecosystems in humans at high risk for infection. Dr. Kelly seeks to understand properties of microbial ecosystems that protect against infection, how microbial ecosystems are altered by antibiotics, and how microbial ecosystems recover from infection and antibiotic treatment. He has performed large, clinical-translational studies to better understand pneumonia and intestinal infections that occur in the setting of critical illness. Dr. Kelly’s work has been supported by the National Institute of Allergy and Infectious Diseases (NIAID) and the Centers for Diseases Control and Prevention (CDC).\n              \n              Education\n              University of Pennsylvania | Philadelphia, PA\n              M.S. in Clinical Epidemiology | July 2011 - August 2013\n              Columbia University College of Physicians & Surgeons | New York, NY\n              M.D. | August 2002 - June 2007\n              Harvard University | Cambridge, MA\n              A.B. in History and Science | September 1998 - June 2002\n              \n              \n              Appointments\n              Assistant Professor of Medicine & Epidemiology | Perelman School of Medicine | University of Pennsylvania\n              Senior Scholar | Center for Clinical Epidemiology & Biostatistics | University of Pennsylvania\n              \n            \n        \n      \n    \n\n    \n    \n    ",
      "last_modified": "2021-02-05T16:30:38-05:00"
    },
    {
      "path": "index.html",
      "title": "Brendan J. Kelly",
      "author": [],
      "contents": "\n\n          \n      \n      Brendan J. Kelly\n      \n      \n      About\n      Projects\n      Publications\n      \n      \n      Teaching\n       \n      ▾\n      \n      \n      Intro to Epidemiology\n      Microbiome Measures\n      \n      \n      News\n      \n      \n      \n      \n      \n      \n      \n      \n      \n      ☰\n      \n      \n      \n        \n          \n            \n              \n            \n              Brendan J. Kelly\n            \n            \n              \n                \n                    \n                      \n                        PubMed\n                      \n                    \n                  \n                                    \n                    \n                      \n                        GitHub\n                      \n                    \n                  \n                                    \n                    \n                      \n                        CV\n                      \n                    \n                  \n                                    \n                    \n                      \n                        Twitter\n                      \n                    \n                  \n                                  \n            \n          \n        \n        \n        \n          \n            Brendan J. Kelly, M.D., M.S., studies infectious diseases and epidemiology at the University of Pennsylvania. His research focuses on microbial ecosystems in humans at high risk for infection. Dr. Kelly seeks to understand properties of microbial ecosystems that protect against infection, how microbial ecosystems are altered by antibiotics, and how they recover from infection and antibiotic treatment. He has performed large, clinical-translational studies to better understand two infections that occur commonly during critical illness: bacterial pneumonia and C. difficile colitis. He has also investigated the use of fecal microbiota transplant (FMT) to aid the recovery of the intestinal microbiome after C. difficile treatment. His work has been supported by the National Institute of Allergy and Infectious Diseases (NIAID) and the Centers for Disease Control and Prevention (CDC).\n            \n            Education\n            University of Pennsylvania | Philadelphia, PA\n            M.S. in Clinical Epidemiology 2013\n            Columbia University | New York, NY\n            M.D. 2007\n            Harvard University | Cambridge, MA\n            A.B. in History and Science 2002\n            \n            \n            Appointments\n            Assistant Professor of Medicine & Epidemiology\n            Perelman School of Medicine | University of Pennsylvania\n            Senior Scholar\n            Center for Clinical Epidemiology & Biostatistics | University of Pennsylvania\n            \n          \n        \n      \n    \n\n    \n      \n        \n          \n            \n              \n            \n              Brendan J. Kelly\n            \n            \n              \n                \n                                    \n                    \n                      PubMed\n                    \n                  \n                                    \n                    \n                      GitHub\n                    \n                  \n                                    \n                    \n                      CV\n                    \n                  \n                                    \n                    \n                      Twitter\n                    \n                  \n                                  \n              \n            \n            \n              Brendan J. Kelly, M.D., M.S., studies infectious diseases and epidemiology at the University of Pennsylvania. His research focuses on microbial ecosystems in humans at high risk for infection. Dr. Kelly seeks to understand properties of microbial ecosystems that protect against infection, how microbial ecosystems are altered by antibiotics, and how they recover from infection and antibiotic treatment. He has performed large, clinical-translational studies to better understand two infections that occur commonly during critical illness: bacterial pneumonia and C. difficile colitis. He has also investigated the use of fecal microbiota transplant (FMT) to aid the recovery of the intestinal microbiome after C. difficile treatment. His work has been supported by the National Institute of Allergy and Infectious Diseases (NIAID) and the Centers for Disease Control and Prevention (CDC).\n              \n              Education\n              University of Pennsylvania | Philadelphia, PA\n              M.S. in Clinical Epidemiology 2013\n              Columbia University | New York, NY\n              M.D. 2007\n              Harvard University | Cambridge, MA\n              A.B. in History and Science 2002\n              \n              \n              Appointments\n              Assistant Professor of Medicine & Epidemiology\n              Perelman School of Medicine | University of Pennsylvania\n              Senior Scholar\n              Center for Clinical Epidemiology & Biostatistics | University of Pennsylvania\n              \n            \n        \n      \n    \n\n    \n    \n    ",
      "last_modified": "2021-02-05T16:30:38-05:00"
    },
    {
      "path": "intro_epi.html",
      "title": "Introduction to Epidemiology",
      "author": [],
      "contents": "\n\n.shareagain-bar {\n--shareagain-foreground: rgb(255, 255, 255);\n--shareagain-background: rgba(0, 0, 0, 0.5);\n--shareagain-facebook: none;\n--shareagain-linkedin: none;\n--shareagain-pinterest: none;\n--shareagain-pocket: none;\n--shareagain-reddit: none;\n}\n\nfitvids('.shareagain', {players: 'iframe'});\n\n\n\n\n",
      "last_modified": "2021-02-05T16:30:38-05:00"
    },
    {
      "path": "microbiome_measures.html",
      "title": "Measuring the Microbiome: Methods and Tools",
      "author": [],
      "contents": "\nMeasuring the Microbiome\n\n.shareagain-bar {\n--shareagain-foreground: rgb(255, 255, 255);\n--shareagain-background: rgba(0, 0, 0, 0.5);\n--shareagain-facebook: none;\n--shareagain-linkedin: none;\n--shareagain-pinterest: none;\n--shareagain-pocket: none;\n--shareagain-reddit: none;\n}\n\nfitvids('.shareagain', {players: 'iframe'});\n\nSequences to Counts\n\n.shareagain-bar {\n--shareagain-foreground: rgb(255, 255, 255);\n--shareagain-background: rgba(0, 0, 0, 0.5);\n--shareagain-facebook: none;\n--shareagain-linkedin: none;\n--shareagain-pinterest: none;\n--shareagain-pocket: none;\n--shareagain-reddit: none;\n}\n\nfitvids('.shareagain', {players: 'iframe'});\n\nAlpha Diversity\n\n.shareagain-bar {\n--shareagain-foreground: rgb(255, 255, 255);\n--shareagain-background: rgba(0, 0, 0, 0.5);\n--shareagain-facebook: none;\n--shareagain-linkedin: none;\n--shareagain-pinterest: none;\n--shareagain-pocket: none;\n--shareagain-reddit: none;\n}\n\nfitvids('.shareagain', {players: 'iframe'});\n\nBeta Diversity\n\n.shareagain-bar {\n--shareagain-foreground: rgb(255, 255, 255);\n--shareagain-background: rgba(0, 0, 0, 0.5);\n--shareagain-facebook: none;\n--shareagain-linkedin: none;\n--shareagain-pinterest: none;\n--shareagain-pocket: none;\n--shareagain-reddit: none;\n}\n\nfitvids('.shareagain', {players: 'iframe'});\n\nRegression Methods for Microbiome Data\n\n.shareagain-bar {\n--shareagain-foreground: rgb(255, 255, 255);\n--shareagain-background: rgba(0, 0, 0, 0.5);\n--shareagain-facebook: none;\n--shareagain-linkedin: none;\n--shareagain-pinterest: none;\n--shareagain-pocket: none;\n--shareagain-reddit: none;\n}\n\nfitvids('.shareagain', {players: 'iframe'});\n\nMore Regression Methods for Microbiome Data\n\n.shareagain-bar {\n--shareagain-foreground: rgb(255, 255, 255);\n--shareagain-background: rgba(0, 0, 0, 0.5);\n--shareagain-facebook: none;\n--shareagain-linkedin: none;\n--shareagain-pinterest: none;\n--shareagain-pocket: none;\n--shareagain-reddit: none;\n}\n\nfitvids('.shareagain', {players: 'iframe'});\n\n\n\n\n",
      "last_modified": "2021-02-05T16:30:39-05:00"
    },
    {
      "path": "news.html",
      "title": "",
      "author": [],
      "contents": "\n\n\n\n",
      "last_modified": "2021-02-05T16:30:39-05:00"
    },
    {
      "path": "projects.html",
      "title": "Projects",
      "author": [],
      "contents": "\n\n\n\n\n\n\n",
      "last_modified": "2021-02-05T16:30:39-05:00"
    },
    {
      "path": "publications.html",
      "title": "Publications",
      "author": [],
      "contents": "\n\nhtml {\n  font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Helvetica Neue', 'Fira Sans', 'Droid Sans', Arial, sans-serif;\n}\n\n#yrrjqgdpjv .gt_table {\n  display: table;\n  border-collapse: collapse;\n  margin-left: auto;\n  margin-right: auto;\n  color: #333333;\n  font-size: 20px;\n  font-weight: normal;\n  font-style: normal;\n  background-color: #FFFFFF;\n  width: auto;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #A8A8A8;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #A8A8A8;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n}\n\n#yrrjqgdpjv .gt_heading {\n  background-color: #FFFFFF;\n  text-align: center;\n  border-bottom-color: #FFFFFF;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#yrrjqgdpjv .gt_title {\n  color: #333333;\n  font-size: 125%;\n  font-weight: initial;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  border-bottom-color: #FFFFFF;\n  border-bottom-width: 0;\n}\n\n#yrrjqgdpjv .gt_subtitle {\n  color: #333333;\n  font-size: 85%;\n  font-weight: initial;\n  padding-top: 0;\n  padding-bottom: 4px;\n  border-top-color: #FFFFFF;\n  border-top-width: 0;\n}\n\n#yrrjqgdpjv .gt_bottom_border {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#yrrjqgdpjv .gt_col_headings {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: black;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: black;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#yrrjqgdpjv .gt_col_heading {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 20px;\n  font-weight: normal;\n  text-transform: inherit;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  padding-left: 5px;\n  padding-right: 5px;\n  overflow-x: hidden;\n}\n\n#yrrjqgdpjv .gt_column_spanner_outer {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 20px;\n  font-weight: normal;\n  text-transform: inherit;\n  padding-top: 0;\n  padding-bottom: 0;\n  padding-left: 4px;\n  padding-right: 4px;\n}\n\n#yrrjqgdpjv .gt_column_spanner_outer:first-child {\n  padding-left: 0;\n}\n\n#yrrjqgdpjv .gt_column_spanner_outer:last-child {\n  padding-right: 0;\n}\n\n#yrrjqgdpjv .gt_column_spanner {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: black;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  overflow-x: hidden;\n  display: inline-block;\n  width: 100%;\n}\n\n#yrrjqgdpjv .gt_group_heading {\n  padding: 8px;\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#yrrjqgdpjv .gt_empty_group_heading {\n  padding: 0.5px;\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#yrrjqgdpjv .gt_from_md > :first-child {\n  margin-top: 0;\n}\n\n#yrrjqgdpjv .gt_from_md > :last-child {\n  margin-bottom: 0;\n}\n\n#yrrjqgdpjv .gt_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  margin: 10px;\n  border-top-style: solid;\n  border-top-width: 1px;\n  border-top-color: black;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n  overflow-x: hidden;\n}\n\n#yrrjqgdpjv .gt_stub {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-right-style: solid;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  padding-left: 12px;\n}\n\n#yrrjqgdpjv .gt_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#yrrjqgdpjv .gt_first_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n}\n\n#yrrjqgdpjv .gt_grand_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#yrrjqgdpjv .gt_first_grand_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: double;\n  border-top-width: 6px;\n  border-top-color: #D3D3D3;\n}\n\n#yrrjqgdpjv .gt_striped {\n  background-color: rgba(128, 128, 128, 0.05);\n}\n\n#yrrjqgdpjv .gt_table_body {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: black;\n}\n\n#yrrjqgdpjv .gt_footnotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#yrrjqgdpjv .gt_footnote {\n  margin: 0px;\n  font-size: 90%;\n  padding: 4px;\n}\n\n#yrrjqgdpjv .gt_sourcenotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#yrrjqgdpjv .gt_sourcenote {\n  font-size: 90%;\n  padding: 4px;\n}\n\n#yrrjqgdpjv .gt_left {\n  text-align: left;\n}\n\n#yrrjqgdpjv .gt_center {\n  text-align: center;\n}\n\n#yrrjqgdpjv .gt_right {\n  text-align: right;\n  font-variant-numeric: tabular-nums;\n}\n\n#yrrjqgdpjv .gt_font_normal {\n  font-weight: normal;\n}\n\n#yrrjqgdpjv .gt_font_bold {\n  font-weight: bold;\n}\n\n#yrrjqgdpjv .gt_font_italic {\n  font-style: italic;\n}\n\n#yrrjqgdpjv .gt_super {\n  font-size: 65%;\n}\n\n#yrrjqgdpjv .gt_footnote_marks {\n  font-style: italic;\n  font-size: 65%;\n}\nAuthors\n      Title\n      Journal\n      Link\n    Abdallah HO, Weingart MF, Fuller R, Pegues D, Fitzpatrick R, Kelly BJ\n      Subglottic suction frequency and adverse ventilator-associated events during critical illness\n      Infect Control Hosp Epidemiol\n      http://dx.doi.org/10.1017/ice.2020.1298\n    Richard-Greenblatt M, Ziegler MJ, Bromberg V, Huang E, Abdallah HO, Tolomeo P, Lautenbach E, Glaser L, Kelly BJ\n      Impact of Nasopharyngeal Specimen Quality on SARS-CoV-2 Test Sensitivity\n      medRxiv\n      http://dx.doi.org/10.1101/2020.12.09.20246520\n    Redding LE, Kelly BJ, Stefanovski D, Lautenbach JK, Tolomeo P, Cressman L, Gruber E, Meily P, Lautenbach E\n      Pet Ownership Protects Against Recurrence of Clostridioides difficile Infection\n      Open Forum Infect Dis\n      http://dx.doi.org/10.1093/ofid/ofz541\n    Berry ASF, Kelly BJ, Barnhart D, Kelly DJ, Beiting DP, Baldassano RN, Redding LE\n      Gut microbiota features associated with Clostridioides difficile colonization in puppies\n      PLoS One\n      http://dx.doi.org/10.1371/journal.pone.0215497\n    Ziegler M, Han JH, Landsburg D, Pegues D, Reesey E, Gilmar C, Gorman T, Bink K, Moore A, Kelly BJ, CDC Prevention Epicenters Program\n      Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients With Hematologic Malignancy\n      Open Forum Infect Dis\n      http://dx.doi.org/10.1093/ofid/ofz252\n    Knecht VR, McGinniss JE, Shankar HM, Clarke EL, Kelly BJ, Imai I, Fitzgerald AS, Bittinger K, Bushman FD, Collman RG\n      Molecular analysis of bacterial contamination on stethoscopes in an intensive care unit\n      Infect Control Hosp Epidemiol\n      http://dx.doi.org/10.1017/ice.2018.319\n    Kelly BJ, Lautenbach E, Nachamkin I, Coffin SE, Gerber JS, Fuchs BD, Garrigan C, Han X, Bilker WB, Wise J, Tolomeo P, Han JH, Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program\n      Combined Biomarkers Predict Acute Mortality Among Critically Ill Patients With Suspected Sepsis\n      Crit Care Med\n      http://dx.doi.org/10.1097/CCM.0000000000003137\n    Agarwal R, Bartsch SM, Kelly BJ, Prewitt M, Liu Y, Chen Y, Umscheid CA\n      Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: systematic review, network meta-analysis and cost analysis\n      Clin Microbiol Infect\n      http://dx.doi.org/10.1016/j.cmi.2017.08.028\n    Kelly BJ, Tebas P\n      Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection\n      Chest\n      http://dx.doi.org/10.1016/j.chest.2017.09.002\n    Kelly BJ, Lautenbach E, Nachamkin I, Coffin SE, Gerber JS, Fuchs BD, Garrigan C, Han X, Bilker WB, Wise J, Tolomeo P, Han JH, Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program\n      Combined biomarkers discriminate a low likelihood of bacterial infection among surgical intensive care unit patients with suspected sepsis\n      Diagn Microbiol Infect Dis\n      http://dx.doi.org/10.1016/j.diagmicrobio.2016.01.003\n    Kelly BJ, Imai I, Bittinger K, Laughlin A, Fuchs BD, Bushman FD, Collman RG\n      Composition and dynamics of the respiratory tract microbiome in intubated patients\n      Microbiome\n      http://dx.doi.org/10.1186/s40168-016-0151-8\n    Kelly BJ, Gross R, Bittinger K, Sherrill-Mix S, Lewis JD, Collman RG, Bushman FD, Li H\n      Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA\n      Bioinformatics\n      http://dx.doi.org/10.1093/bioinformatics/btv183\n    Brady T, Kelly BJ, Male F, Roth S, Bailey A, Malani N, Gijsbers R, O’Doherty U, Bushman FD\n      Quantitation of HIV DNA integration: effects of differential integration site distributions on Alu-PCR assays\n      J Virol Methods\n      http://dx.doi.org/10.1016/j.jviromet.2013.01.004\n    Khiabanian H, Holmes AB, Kelly BJ, Gururaj M, Hripcsak G, Rabadan R\n      Signs of the 2009 influenza pandemic in the New York-Presbyterian Hospital electronic health records\n      PLoS One\n      http://dx.doi.org/10.1371/journal.pone.0012658\n    Yu M, Kumar TRS, Nkrumah LJ, Coppi A, Retzlaff S, Li CD, Kelly BJ, Moura PA, Lakshmanan V, Freundlich JS, Valderramos J-C, Vilcheze C, Siedner M, Tsai JH-C, Falkard B, Sidhu ABS, Purcell LA, Gratraud P, Kremer L, Waters AP, Schiehser G, Jacobus DP, Janse CJ, Ager A, Jacobs WR Jr, Sacchettini JC, Heussler V, Sinnis P, Fidock DA\n      The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites\n      Cell Host Microbe\n      http://dx.doi.org/10.1016/j.chom.2008.11.001\n    \n\n\n\n\n",
      "last_modified": "2021-02-05T16:30:41-05:00"
    }
  ],
  "collections": ["posts/posts.json"]
}
